logo
NasdaqGM:IOVA logo

Iovance Biotherapeutics Community

NasdaqGM:IOVA Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 75 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

IOVA logo
Iovance Biotherapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts

US Launch And Global Expansion Will Create New Opportunities

Key Takeaways The U.S. launch of Amtagvi and international expansion could drive significant revenue and market growth, enhancing revenue streams and market share. Manufacturing capacity improvements and economies of scale aim to boost gross margins and profitability significantly.
View narrative
US$20.08
FV
82.6% undervalued intrinsic discount
84.52%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
43users have followed this narrative
4 days ago author updated this narrative